91.5FM
91.5HD2
8.85 c91.5 FM
91.5 HD2
Canada receives report of blood clot linked to AstraZeneca
BY , Apr 13, 2021 8:31 PM - REPORT AN ERROR
Pharmacist Barbara Violo shows off a vial of the Oxford-AstraZeneca COVID-19 vaccine after providing doses to customers at the Junction Chemist which is a independent pharmacy during the COVID-19 pandemic in Toronto on March 12, 2021. THE CANADIAN PRESS/Nathan Denette
Pharmacist Barbara Violo shows off a vial of the Oxford-AstraZeneca COVID-19 vaccine after providing doses to customers at the Junction Chemist which is a independent pharmacy during the COVID-19 pandemic in Toronto on March 12, 2021. THE CANADIAN PRESS/Nathan Denette
Patty Hajdu
A Quebec woman has developed a blood clot after receiving a COVID-19 vaccine, in Canada's first case of the rare condition.
Federal and provincial health officials say the woman got an Oxford-AstraZeneca vaccine that was produced at the Serum Institute of India, known as Covishield.
The agency says the person is now recovering at home.
Health Canada says the side-effect is extremely rare and the vaccine's benefits still outweigh its risks.
More than 700,000 doses of the vaccine have been administered in Canada.
In the House of Commons today, Health Minister Patty Hajdu was asked by the Conservatives whether her department will be conducting a review of the case.
Hajdu said there would be a review, but also accused the Conservative opposition of fear mongering.
Share on
Related News
Sign up for the newsletter
We'll deliver best of entertainment right into your inboxWe love to hear from our listeners, so feel free to send us message
Message us on whatsapp
